Here is the synopsis of our sample research paper on Ventricular Assist Devices Product Life Cycle. Have the paper e-mailed to you 24/7/365.
Essay / Research Paper Abstract
A 6 page paper discussing where ventricular assistive devices (VADs) currently reside on the product life cycle curve; what factors are likely to affect their growth; and how long producers can expect the product to be an active contributor to revenues. Recently approved by the FDA as an artificial heart, VADs are poised to become an end-goal product rather than only a bridge buying time until a heart can be found for transplant. The paper discusses costs and what producers can expect to gain from VADs over the next several years. Bibliography lists 4 sources.
Page Count:
6 pages (~225 words per page)
File: CC6_KSmedVentAsDevProd.rtf
Buy This Term Paper »
Unformatted sample text from the term paper:
Harvards promoter of the idea of disruptive technologies and their effects, Clayton Christensen, turned his attention to the health care industry in 2000. Christensen, Bohmer and Kenagy (2000) explain
that technology generally outpaces individuals ability to fully utilize it, and that such has been the case in health care over the past several years. Though other more dramatic
procedures exist, they are costly and often provide the patient with a higher degree of treatment than his condition requires. Ventricular assist devices
do not necessarily serve the low end of the market in terms of total cost to the patient or insurer, but they do serve the low end of the market
in terms of the procedures and total medical attention they replace. The purpose here is to discuss the devices expected product life cycle. Current Product Life Cycle Stage
Ventricular assist devices exist in the area open to the emergence of disruptive technologies, defined as "simpler, more convenient, and less costly offerings initially
designed to appeal to the low end of the market" (Christensen, Bohmer and Kenagy, 2000; p. 105). The simpler offerings improve so much over time that they ultimately become
better suited to the needs of many consumers, rather than only to those at the low end of the market (Christensen, Bohmer and Kenagy, 2000). The area of disruptive
technology is the same one through which personal computers emerged in a mainframe world, and it is the same one by which angioplasty came to be a standard alternative to
bypass surgery (Christensen, Bohmer and Kenagy, 2000). Product Function The bottom two chambers of the heart are the ventricles, referred to as the
...